首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话15274084725)
药品名称:
商品名称:
药品NDC:
报告期内:
-
格式:2020-5-3
NDC包装id:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC 数据库排除药物数据库文件
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话15274084725)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
del Nido Plasmalyte-A
HUMAN COMPOUNDED DRUG
71285-0202
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
MANNITOL; LIDOCAINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; MAGNESIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM BICARBONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3.26 g/1052.8 mL; 130 mg/1052.8 mL; 16.24 meq/1052.8 mL; .3 g/1052.8 mL; 5.02 g/1052.8 mL; 3.68 g/1052.8 mL; 2.307 g/1052.8 mL; 5.26 g/1052.8 mL; 1.092 g/1052.8 mL
71285-0202-1
Hydromorphone HYDROCHLORIDE CADD
HUMAN COMPOUNDED DRUG
71139-0018
IntegraDose Compounding Services, LLC
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/100 mL
71139-0018-1
Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
71139-7084
IntegraDose Compounding Services, LLC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/10 mL
71139-7084-1
Ephedrine Sulfate
HUMAN COMPOUNDED DRUG
71139-6643
IntegraDose Compounding Services, LLC
2021/2/1 0:00:00
EPHEDRINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/5 mL
71139-6643-1
CEFAZOLIN
HUMAN COMPOUNDED DRUG
71139-7153
IntegraDose Compounding Services, LLC
2021/2/1 0:00:00
CEFAZOLIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3 g/123 mL
71139-7153-1
Magnesium Sulfate (2gm) PF In 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-731
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
MAGNESIUM SULFATE HEPTAHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g
70004-731-30
Sodium Citrate 4%
HUMAN COMPOUNDED DRUG
70004-900
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
TRISODIUM CITRATE DIHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/1 mL
70004-900-25
Hydromorphone 0.2 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-300
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
70004-300-30
Hydromorphone 0.2 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-300
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
70004-300-22
Hydromorphone 0.2 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-300
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
70004-300-55
Hydromorphone 0.2 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-300
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
70004-300-16
Hydromorphone 0.2 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-300
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
70004-300-62
Ketamine 50 mg/mL
HUMAN COMPOUNDED DRUG
70004-433
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
70004-433-05
Hydromorphone 1 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-303
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
70004-303-17
Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
71449-001
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 ug/1 mL
71449-001-11
Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
71449-001
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 ug/1 mL
71449-001-15
Lidocaine Hydrochloride
HUMAN COMPOUNDED DRUG
71449-024
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
71449-024-07
Lidocaine Hydrochloride
HUMAN COMPOUNDED DRUG
71449-024
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
71449-024-11
Bupivacaine, Dexamethasone, Epinephrine
HUMAN COMPOUNDED DRUG
71449-127
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
EPINEPHRINE; BUPIVACAINE HYDROCHLORIDE; DEXAMETHASONE SODIUM PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 ug/1 mL; 3.75 mg/1 mL; .1 mg/1 mL
71449-127-32
Ropivacaine Hydrochloride
HUMAN COMPOUNDED DRUG
71449-124
Denver Solutions, LLC dba Leiters Health
2021/2/1 0:00:00
ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
71449-124-91
1
(current)
2
(current)
3
(current)
4
(current)
5
(current)
6
(current)
7
(current)
8
(current)
9
(current)
10
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:33068302000535
医药代理商群1:
医药代理商群2:
医药代理商群3: